This is a narrative review that discusses how sirtuins (SIRTs) are involved in molecular pathways related to inflammation, oxidative stress, and plaque development in atherosclerosis. The central result is that sirtuins represent a potential novel therapeutic target to stabilize plaques and reduce cardiovascular events, based on a synthesis of existing literature.